Request a Quote

NJ Bio, Inc._Contact

Contact Us

NJ Bio, Inc. Team, Best Contract Research Organization


“When we were looking for a CRO with expertise in the ADC field and one that could work closely with an early-stage company, NJ Bio stepped up to the plate to help. They were able to meet our timelines, provide valuable insight, and deliver several quality ADCs to evaluate in our in vitro and in vivo studies. We will continue to utilize NJ Bio’s services as our internal ADC program continues to mature.”

Founder and CEO, Early Stage Biotech Company

“I want to send you this testimonial in support of working with NJ Bio as our main ADC CRO. Over the last 20 years of ADC work, I have worked with a large number of different CROs in the ADC field. By far, NJ Bio has been the easiest to work with, and the highest quality materials have been produced by their scientists to support our programs. The scientific team at NJ Bio is top tier, and we trust them with our most precious programs. They have successfully produced extremely complicated custom compounds for us, and in impressive turn-around times. Of all the CROs that we work with, we consider NJ Bio to be our main strategic partner and actually have factored our business relationship with them into our future growth plans.”

Director, Process Development & Technical Transfer, ADC Platform Company

“We have worked with a number of CROs in the past, but feel we have found an ideal, long-term partner with NJ Bio for our antibody drug conjugate activities. NJ Bio has been open to accommodate changes beyond agreed scope to improve quality or adapting to different needs. The expert team at NJ Bio is highly competent and the project progress was presented and discussed on a regular basis to achieve our goals on time.”

Director of Antibody Research, European-based Company

“NJ Biopharma was challenged to synthesize novel phosphoramidites at the gram scale for our company. The team quickly divided up the task and probed which synthetic route would be scalable. With minor tweaks to each phosphoramidite, the team completed each target in a time frame that matched our needs perfectly. A variety of characterization was supplied including phosphorus NMR, and 2D homonuclear spectra. We would trust further projects to be carried out by NJ Biopharma in the future to be of similar quality and timeliness.”

Director, Large US-based Biotech Company